AN2 Therapeutics Competitors and Similar CompaniesClear all
AN2 Therapeutics's competitors and similar companies include Genor Biopharma, Sanofi Genzyme and Roivant Sciences.
 Genor Biopharma Genor Biopharma is a company that manufactures antibodies and related biological products. |  Sanofi Genzyme Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology. | |||
Founding Date | Founding Date 2019 | Founding Date 2007 | Founding Date 1981 | Founding Date 2014 |
Type | Type Public | Type Private | Type Subsidiary | Type Public |
Tags | ||||
Locations | Locations Menlo Park, US HQ | Locations CN HQ | Locations Cambridge, US HQ Macquarie Park, AU Malaga, AU Virginia, AU São Paulo, BR Mississauga, CA Toronto, CA see more | Locations London, GB HQ Basel, CH Boston, US New York, US |
Employees | Employees 22 | Employees 22245% decrease | Employees 9,9041% decrease | Employees 908 |
Valuation ($) | Valuation ($) 33.1 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 8.8 b |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) €10.4b (FY, 2019) | Revenue (est.) $8.3m (FY, 2025) |
Net income | Net income ($35.2m) (FY, 2025) | Net income N/A | Net income N/A | Net income ($397.9m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 12m | Total funding raised $ 212m | Total funding raised N/A | Total funding raised $ 1.9b |
For sources of this data, please see the company profile
View Company Profiles
Genor Biopharma
HQ
CN
Employees
222↓ 45% decrease
Genor Biopharma is a company that manufactures antibodies and related biological products.
View companySanofi Genzyme
HQ
Cambridge, US
Sanofi Genzyme (also known as Genzyme Corporation) is a biotech company that specializes in rare diseases, rare blood disorders, multiple sclerosis, oncology, and immunology.
View company
Roivant Sciences
HQ
London, GB
Employees
908
Roivant Sciences is a company that develops and commercializes medicines.
View company